Cervical, colorectal, lung, and pancreatic carcinoma patients presented discrepant and, therefore, inconclusive results regarding the association between tumour HLA-G expression and clinical outcome. The gene discussed is HLA-G; the disease is exocrine pancreatic carcinoma.